CLMT vs TECH
Calumet Specialty Products Partners (CLMT) versus Bio-Techne Corp (TECH) — a side-by-side from cached financials, not a winner call.
Calumet Specialty Products Partners (CLMT) is a specialty chemicals company listed on NASDAQ.
Bio-Techne Corp (TECH) is a biotechnology company listed on US.
Latest reported CLMT revenue for 2024-12-31 was $4.19B. Net income was -$222.0M. Revenue was up 0.2% from 2023-12-31 to 2024-12-31. CLMT currently screens at market cap $2.89B.
Latest reported TECH revenue for 2025-06-30 was $1.22B. Net income was $73.4M. Revenue was up 5.2% from 2024-06-30 to 2025-06-30. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
CLMT currently screens at market cap $2.89B. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
Not investment advice. Open the CLMT and TECH stock pages for the full models.
Not investment advice.